Stocks / NASDAQ / Pluristem Therapeutics, Inc.

Pluristem Therapeutics, Inc.

Our Opinion

Pluristem Therapeutics is on the Cruelty Free Investing list for exploiting animals because the company does animal testing for some of their medical research and therapies.

Supporting Evidence:

Report that specifies that the company conducts animal testing

“Racheli Ofir, Ph.D., Pluristem’s Vice President of Research & Intellectual Property, shared her expertise in studying the treatment of Acute Radiation Syndrome (ARS) in a variety of animal models. “

Company Description

Pluristem Therapeutics Inc., incorporated on May 10, 2001, is a developer of placenta-based cell therapy product candidates for the treatment of multiple ischemic, inflammatory and hematologic conditions. The Company’s lead indications are critical limb ischemia (CLI), recovery after surgery for femoral neck fracture and acute radiation syndrome. [Source: Reuters]

Company Website: